Skip to main content
Top
Published in: Neuroradiology 3/2009

01-03-2009 | Diagnostic Neuroradiology

Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel 1H-MRS at 1.5 T

Authors: Mikhail F. Chernov, Yoshihiro Muragaki, Takashi Maruyama, Yuko Ono, Masao Usukura, Shigetoshi Yoshida, Ryoichi Nakamura, Hiroshi Iseki, Osami Kubo, Tomokatsu Hori, Kintomo Takakura

Published in: Neuroradiology | Issue 3/2009

Login to get access

Abstract

Introduction

The present study was done for evaluation of the possible influence of the oral administration of choline on metabolic characteristics of gliomas detected with proton magnetic resonance spectroscopy (1H-MRS).

Materials and methods

Thirty patients (22 men and eight women; mean age 38 ± 15 years) with suspicious intracranial gliomas underwent single-voxel long-echo (TR 2,000 ms, TE 136 ms, 128–256 acquisitions) 1H-MRS of the tumor, peritumoral brain tissue, and distant normal-appearing white matter before and several hours (median, 3 h; range, 1.2–3.7 h) after ingestion of choline with prescribed dose of 50 mg/kg (median actual dose, 52 mg/kg; range, 48–78 mg/kg). Investigations were done using 1.5 T clinical magnetic resonance imager. The volume of the rectangular 1H-MRS voxel was either 3.4 or 8 cm3. At the time of both spectroscopic examinations, similar voxels’ positioning and size and technical parameters of 1H-MRS were used. Surgery was done in 27 patients within 1 to 68 days thereafter. In all cases, more than 80% resection of the neoplasm was attained.

Results

There were 12 low-grade gliomas and 15 high-grade gliomas. MIB-1 index varied from 0% to 51.7% (median, 13.8%). Statistical analysis did not disclose significant differences of any investigated metabolic parameter of the tumor, peritumoral brain tissue and distant normal-appearing white matter between two spectroscopic examinations.

Conclusion

Single-voxel 1H-MRS at 1.5 T could not detect significant changes of the metabolic characteristics of gliomas, peritumoral brain tissue, and distant normal-appearing white matter after oral administration of choline.
Literature
1.
go back to reference Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381, doi:10.1007/s00234-001-0760-0 PubMedCrossRef Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381, doi:10.​1007/​s00234-001-0760-0 PubMedCrossRef
4.
go back to reference Chinn RJS, Wilkinson ID, Hall-Craggs MA, Paley MNJ, Miller RF, Kendall BE, Newman SP, Harrison MJG (1995) Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 197:649–654PubMed Chinn RJS, Wilkinson ID, Hall-Craggs MA, Paley MNJ, Miller RF, Kendall BE, Newman SP, Harrison MJG (1995) Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 197:649–654PubMed
5.
go back to reference Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P (1998) Localised 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64:516–523PubMedCrossRef Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P (1998) Localised 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64:516–523PubMedCrossRef
7.
go back to reference Park SW, Chang KH, Kim HD, Song IC, Lee DS, Lee SK, Chung CK, Yu IK, Han MH, Park YH (2001) Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 22:625–631PubMed Park SW, Chang KH, Kim HD, Song IC, Lee DS, Lee SK, Chung CK, Yu IK, Han MH, Park YH (2001) Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 22:625–631PubMed
8.
go back to reference Butteriss DJA, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665, doi:10.1259/bjr/85069069 PubMedCrossRef Butteriss DJA, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665, doi:10.​1259/​bjr/​85069069 PubMedCrossRef
9.
go back to reference Mader I, Rauer S, Gall P, Klose U (2008) 1H MR spectroscopy of inflammation, infection, and ischemia of the brain. Eur J Radiol 67:250–257PubMedCrossRef Mader I, Rauer S, Gall P, Klose U (2008) 1H MR spectroscopy of inflammation, infection, and ischemia of the brain. Eur J Radiol 67:250–257PubMedCrossRef
10.
go back to reference Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM (1995) Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 37:170–174, doi:10.1016/0006-3223(94)00120-R PubMedCrossRef Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM (1995) Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 37:170–174, doi:10.​1016/​0006-3223(94)00120-R PubMedCrossRef
12.
go back to reference Hara T, Kosaka N, Shinoura N, Kondo T (1997) PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38:842–847PubMed Hara T, Kosaka N, Shinoura N, Kondo T (1997) PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38:842–847PubMed
13.
go back to reference Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474–479PubMedCrossRef Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474–479PubMedCrossRef
14.
go back to reference Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62:329–338, doi:10.1023/A:1023342516925 PubMedCrossRef Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62:329–338, doi:10.​1023/​A:​1023342516925 PubMedCrossRef
16.
go back to reference Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176–1182, doi:10.3174/ajnr.A1008 PubMedCrossRef Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176–1182, doi:10.​3174/​ajnr.​A1008 PubMedCrossRef
17.
go back to reference Kleihues P, Cavenee WK (eds) (2000) In: Pathology and genetics of tumours of the nervous system. IARC, Lyon Kleihues P, Cavenee WK (eds) (2000) In: Pathology and genetics of tumours of the nervous system. IARC, Lyon
18.
go back to reference Rand SD, Prost R, Li SJ (1999) Proton MR spectroscopy of the brain. Neuroimaging Clin N Am 9:379–395PubMed Rand SD, Prost R, Li SJ (1999) Proton MR spectroscopy of the brain. Neuroimaging Clin N Am 9:379–395PubMed
19.
Metadata
Title
Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel 1H-MRS at 1.5 T
Authors
Mikhail F. Chernov
Yoshihiro Muragaki
Takashi Maruyama
Yuko Ono
Masao Usukura
Shigetoshi Yoshida
Ryoichi Nakamura
Hiroshi Iseki
Osami Kubo
Tomokatsu Hori
Kintomo Takakura
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Neuroradiology / Issue 3/2009
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-008-0471-x

Other articles of this Issue 3/2009

Neuroradiology 3/2009 Go to the issue